Semiquantitative RT-PCR was used to demonstrate that NDRG2 expression levels were reduced in squamous cell carcinoma, pancreatic cancer and glioblastoma compared to normal tissue [4,9,11]. The gene discussed is NDRG2; the disease is glioblastoma.